Mammography computer-aided detection firm R2 Technology took another step toward going public last month when it presented its lead product and its business plan to the investment community. Appearing at the Hambrecht & Quist Health Care Conference
Mammography computer-aided detection firm R2 Technology took another step toward going public last month when it presented its lead product and its business plan to the investment community. Appearing at the Hambrecht & Quist Health Care Conference in San Francisco, the company highlighted ImageChecker M1000, its mammography CAD workstation.
R2 of Los Altos, CA, is operating with venture capital backing, but the company sees an initial public offering in its future, according to James Pell, president and CEO. A tight stock market isn't always receptive to early-stage IPOs, however, so R2 plans to demonstrate a strong sales record with ImageChecker before pursuing an offering, Pell said. As such, the company has yet to file documents with the Securities and Exchange Commission.
The company considered taking the public plunge in 1996, but decided against the move when the market took a downturn. Now R2 may have a stronger position: In April, it signed an exclusive agreement with GE Medical Systems that will allow GEMS to package ImageChecker with its full-field digital mammography system (SCAN 4/29/98).
In July, R2 received clearance for ImageChecker for use with digitized mammography films (SCAN 7/22/98). Outside the U.S., R2 has sold two ImageChecker units and has placed roughly nine more in pilot screening programs. Since receiving FDA clearance, the company has sold about 16 ImageCheckers in the U.S. ImageChecker lists for approximately $180,000.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.